Skip to main content
. 2019 Feb 27;10:304. doi: 10.3389/fimmu.2019.00304

Figure 4.

Figure 4

DAB2 is downregulated in human and murine dendritic cells after Toll-like receptor activation through MyD88 and TRIF pathways. (A) Bone-marrow derived dendritic cells (BMDC) differentiated from C57BL/6J mice, DC2.4 cells, and human monocytes-derived dendritic cells were incubated with 100 ng/mL LPS, and DAB2 expression was quantified using western blotting. (B) DAB2 expression in BMDCs treated with agonist for extracellular TLR or (C) agonist for intracellular TLR. (D,E) DAB2 expression after treatment with HKLM, HMW, or LPS in BMDC differentiated from WT, MyD88−/−, and or TRIF−/− C57BL/6 mice. Bar graphs represent mean values of three independent experiments combined (n = 3 mice, **p < 0.01, ****p < 0.001 treatment vs. Ctrl within the same genetic background).